Kai Zhang
Directeur/Membre du Conseil chez NKD Pharma Co., Ltd.
Profil
Kai Zhang is a member of the supervisory board at NKD Pharma Co., Ltd.
since 2020.
He completed his undergraduate degree at Shanghai University of Finance & Economics.
Postes actifs de Kai Zhang
Sociétés | Poste | Début |
---|---|---|
NKD Pharma Co., Ltd.
NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 01/10/2020 |
Formation de Kai Zhang
Shanghai University of Finance & Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
NKD Pharma Co., Ltd.
NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Health Technology |